Results
Globally, we evaluated 70 patients (49 males, 21 females; mean (SD) age, 14.3 ± 1.9 years; age range 10-18). The patients’ demographic and clinical characteristics and sensitization are reported in Table 1. All 70 patients received SLIT up to three years, with 100% treatment adherence for SLIT throughout the study duration. 62 (89%) out of 70 included patients received SLIT continuously, 8 (11%) out of 70 patients received SLIT pre-coseasonally. No AEs were reported during the study.